shaghayegh saharkhizcover image
shaghayegh saharkhizavatar

shaghayegh saharkhiz

I was born in 1993 I hold a master's degree in Nanobiotechnology from University of Isfahan, Iran. In addition, I was graduated in biology bachelor's from shiraz university. I have served as a research assistant for 5 years at 2 elite universities in my hometown. Now, I am seeking for a PhD position now.
Living in : Iran
Gender : FemaleRace : Middle Eastern
Academic Profile
Posts

Contact Information

-Email
logo
shaghayeghsaharkhizApplyChance Link

Educations

University of Isfahan logo
Biomedical Engineering And BiotechnologyMaster'sUniversity of Isfahan2020-11-19 Iran

Work Experiences

research assisstant
at Shiraz University of Medi
I am currently working in this role
Research assistant
at University of Isfahan
Start : 23-Apr-2021
End : 22-Jun-2023

English Scores

IELTS01-Jan-0001
7/9Total
Reading :
0/9
Speaking :
0/9
Listening :
0/9
Writing :
0/9

Conferences

Your Presentation Title :
A comparison study between doxorubicin and curcumin coadministration and co-loading in a smart niosomal formulation for breast cancer therapy poster
Conference Name :The 6th Spanish Conference on
Spain
2023

Journal Publications

Publication Title :
Evaluating a targeted Palbociclib-Trastuzumab loaded smart niosome platform for treating HER2 positive breast cancer cellsFirst author
Journal :
International Journal of Pharmaceutics
Link :
Publication Title :
Thermo- and pH-responsive targeted lipid-coated mesoporous nano silica platform for dual delivery of paclitaxel and gemcitabine to overcome HER2-positive breast cancerSecond author
Journal :
International Journal of Pharmaceutics
Link :
Publication Title :
Down-regulation of PEAR1 and its regulatory factor, LINC00271, as the potential novel tumor suppressors in breast cancer: bioinformatics and experimental approachCorresponding author
Link :
Publication Title :
A comparison study between doxorubicin and curcumin coadministration and co-loading in a smart niosomal formulation for MCF-7 breast cancer therapy,First author
Journal :
European Journal of Pharmaceutical Sciences
Link :
Publication Title :
Development of a new smart theranostic anti-PSMA-aptamer conjugated cationiclipid coated mesoporous silica platform for targeted delivery of paclitaxel and CdSe/ZnS quantum dots to LNCaP cell lineFirst author
Journal :
Journal of Drug Delivery Science and Technology
Link :
Publication Title :
A new theranostic pH-responsive niosome formulation for doxorubicin delivery and bioimaging against breast cancerFirst author
Journal :
International Journal of Pharmaceutics
Link :
Publication Title :
Shirzadi Ghalehshahi, S, Saharkhiz, S, Naderi, N, Nasri, Development of pH and thermo-responsive smart niosomal carriers for delivery of gemcitabine to the breast cancer cells)Second author
Link :
Publication Title :
In Vitro study of a new theranostic smart niosomal nanostructure for direct delivery of docetaxel via anti-PSMA aptamerSecond author
Journal :
Heliyon
Link :
Publication Title :
Empowering Cancer Therapy: Comparing PEGylated and Non-PEGylated Niosomes Loaded with Curcumin and Doxorubicin on MCF-7 Cell LineFirst author
Link :

Research Keywords

Drug delivery
Tissue engineering
cancer
monoclonal antibody
nanomedicine
Aptamer
Niosome
3D-printing
Theranostic
Liposome
targeted delivery
lipid-nanoparticles
gene-delivery
pH-sensitive
thermosensitive
biomedical enginineering

References

Ali Zarrabi
Ali.zarrabi@istinye.edu.tr
Ghasem Dini
g.dini@sci.ui.ac.ir
Arezoo Khosravi
arezoo.khosravi@okan.edu.tr
Mansoureh Azadeh
mazadeh@phd.iaurasht.ac.ir